Alaska Blind Child Discovery
11
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
ROP Check Database Premature Infant Outcomes
Role: lead
Treating Amblyopia With CureSight
Role: lead
Autostereoscopic Dynamic Near Vision Testing
Role: lead
The Alaska Oculocardiac Reflex Study
Role: lead
Performance of 2WIN Photoscreener With Corneal Reflex Compared to School Bus Retinoscopy by AAPOS Guidelines
Role: lead
Refractive Accuracy of "2WIN" and Portable Autorefractors
Role: lead
Comparative Validation of "Blinq" and "2WIN" Vision Screeners
Role: lead
Hyperopia Detection GCK With Glow Fixation
Role: lead
Enhanced Housing Photoscreeners 2WIN and GoCheckKids Compared in Burma and Alaska
Role: lead
Oculocardiac Reflex Brain Wave Monitor
Role: lead
Strabismus Recovery With Proparacaine and Oculocardiac Reflex
Role: lead
All 11 trials loaded